Singapore GLP-1 clinics deeper-cut 2026: per-clinic pricing, MOH posture, Bangkok-hop tradeoff
The Singapore GLP-1 clinic layer beyond the existing buyers guide. Per-clinic pricing for the four most-routable Singapore providers, MOH-licensed-product reality, the Wegovy-vs-Ozempic supply picture, and when the 2h20 Bangkok flight beats the local cost.
The existing Singapore buyers guide covers the regulatory frame and the four-clinic shape. This post goes one click deeper · per-clinic 2026 pricing on what's actually in stock, MOH-licensed-product specifics, and the cost calculation that pushes a meaningful share of SG-resident expats onto the 2h20 Bangkok-hop relationship for resupply while keeping a Singapore clinic anchor for continuity.
What MOH licenses today
The Singapore Health Sciences Authority maintains the active register of weight-management medications. As of May 2026 the register includes:
- Wegovy (semaglutide 2.4mg) · weight-management indication, prescribed at private clinics + MOH-licensed pharmacies
- Ozempic (semaglutide diabetes label) · diabetes indication, off-label weight-management prescribing common but not insured under most private plans for that use
- Mounjaro (tirzepatide diabetes label) · diabetes indication, similar off-label dynamics
- Saxenda (liraglutide 3.0mg) · weight-management indication, daily injection
Zepbound (tirzepatide weight-management label) is not yet on the SG active register as of May 2026. Wegovy is the cleanest weight-management-indication route; Mounjaro is the cleanest tirzepatide route via diabetes prescribing and off-label use.
Per-clinic pricing, May 2026
Premium private clinics in Singapore run higher than the Bangkok premium-hospital tier. The four most-routable Singapore GLP-1 providers in our catalog:
| Clinic | Wegovy 2.4mg | Mounjaro 5mg | Mounjaro 10mg | Consult fee |
|---|
Converted to USD at the May 2026 rate: roughly USD 660 to 1,030 for Wegovy, USD 510 to 1,000 for Mounjaro depending on dose. Compare to the Bangkok mid-tier pricing of USD 220 to 460 for Mounjaro 5mg to 10mg + the USD 90 to 220 round-trip flight.
The Bangkok-hop math from Singapore
Singapore is the geographically-closest expat market to Bangkok in our SE Asia matrix. SQ + Scoot + Thai + AirAsia all run multiple daily SIN-BKK flights at 2h20. Round-trip economy 30-day-advance booking lands USD 90 to 220 off-peak.
The break-even calculation per pen, comparing same-dose Mounjaro at the Singapore mid-tier vs the Bangkok mid-tier with one round-trip flight:
- Singapore Mounjaro 5mg per month: ~USD 510 (no flight)
- Bangkok Mounjaro 5mg per month + flight amortized over 8-week supply: ~USD 220 + ~USD 75 flight share = ~USD 295
The Bangkok hop saves roughly USD 200 to 300 per month at the mid-tier even with the flight cost factored in. At higher doses (10mg, 12.5mg, 15mg) the absolute savings grow proportionally because the per-pen price scales with dose.
The cost-equation does not include time. A round-trip Bangkok visit takes a half-day each way + a clinic appointment in Bangkok = roughly one full work-day of opportunity cost every 8 to 12 weeks. For SG residents whose hourly rate is high enough to make that calculation favor staying, the local-clinic premium is the right answer. For everyone else the Bangkok hop math wins.
When to keep a Singapore clinic anchor anyway
Two scenarios where a Singapore clinic relationship still earns its keep:
1. Insurance coverage. Some Singapore private health plans (Aviva, Prudential, AIA) cover Wegovy at MOH-licensed clinics with the weight-management indication. None of them reimburse the Bangkok-hop pen. If your insurance covers ~70% of the SG private cost, the local route wins on out-of-pocket. 2. Clinical continuity for complex cases. Patients with comorbid conditions (T2D, cardiovascular disease, kidney function questions) benefit from a SG-based clinical relationship for the labs and the integrated specialist consults. The Bangkok-hop is well-suited for the GLP-1 prescription itself but not for the broader clinical picture.
What we route to
The matchmaker quiz at /quiz routes Singapore-resident users by goal cluster, urgency, and budget signal. SG users who pick "ready" + "full optimization" + premium-budget land on the Singapore-clinic route by default. SG users who pick "ready" + "meaningful" + cost-conscious-budget land on a hybrid recommendation: Bangkok-hop for the prescription + Singapore-clinic for labs and follow-up.
The full per-vendor scorecards for the SG-routable clinics live at /vendor. The Bangkok-hop playbook with the cross-border mechanics is at /blog/bangkok-glp1-hop-expat-playbook-2026.
We earn a small commission when you buy through recommended vendors. That is how this stays free. Vendors rank by quality signals, not paid placement.
After the FDA crackdown: the state of US compounded GLP-1 in May 2026
Five months after the FDA closed enforcement discretion on 503A and 503B compounded tirzepatide and semaglutide, the US compounded-GLP-1 landscape has consolidated, contracted, and fragmented. The April 30 scorecard recap captured the snapshot. This is what changed in the four weeks after.
Bali GLP-1 supply tactical update May 2026: what's actually in stock at each clinic this month
BPOM intermittency means the existing Bali buyers guide gets stale fast. This is the May 2026 supply-state tactical · per-clinic Mounjaro and Ozempic stocking, the most-current expat-routable picks, and the Bangkok-hop fallback when the nomad-clinic layer has gaps.
The Bangkok GLP-1 hop: a practical playbook for expats in Bali, Singapore, Hanoi, HCMC, KL, Manila
Bangkok is the regional anchor for legitimately-supplied tirzepatide and semaglutide in Southeast Asia. Flight matrices, clinic-relationship cadence, cold-chain transit, customs personal-use rules per origin country, and the four-versus-twelve-week supply math.